Standout Papers

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis 2004 2026 2011 2018 1.9k
  1. Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis (2004)
    Jonathan Edwards, L Szczepański et al. New England Journal of Medicine
  2. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis (2023)
    Gerd R Burmester, Stanley Cohen et al. RMD Open

Immediate Impact

21 from Science/Nature 66 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
2 intermediate papers

Works of Tim Shaw being referenced

Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
2021
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout

Author Peers

Author Last Decade Papers Cites
Tim Shaw 1289 458 565 883 632 15 2.4k
D. Close 1456 438 539 1166 796 25 2.9k
Mark C. Totoritis 1223 420 461 858 638 15 2.1k
L Szczepański 1622 551 711 1033 789 18 3.9k
E. Hessey 1674 638 703 719 607 8 2.3k
R. John Looney 1012 246 439 1323 694 25 2.5k
Anna Filipowicz‐Sosnowska 1709 581 718 1063 785 36 3.3k
Michael E. Luggen 1855 751 491 866 400 43 2.9k
Matthew Cravets 1077 455 466 604 388 6 1.9k
Ken J. Bulpitt 1880 875 324 766 374 32 2.9k
Raymond E. Felgar 791 264 524 1334 672 38 2.7k

All Works

Loading papers...

Rankless by CCL
2026